In this discussion, an EU-based KOL speaks about current treatment trends, focusing on the safety and efficacy of each treatment option. He also speaks about newer drugs replacing the currently marketed treatments, and on the pipeline therapies which are showing promise. 

This interview was conducted on 9 November 2023. 

If you are a KOL Insight Subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker's KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.

For our disclosures, please read the Biomedtracker Research Standards.